Clone Robotics
Wroclaw developer (founded 2021) of musculoskeletal androids driven by water-powered Myofiber artificial muscles: Clone Hand and the Clone Alpha android.
Clone (Clone Robotics) develops biomimetic, musculoskeletal humanoid robots in which anatomically modelled skeletons are moved by artificial muscles rather than electric joint motors. It was formally incorporated in late 2021 by Dhanush Radhakrishnan (CEO) and Lukasz Kozlik (CTO), operates as Clone Sp. z o.o. in Wroclaw, Poland and Clone, Inc. in the United States, and opened a second office in Mountain View, California in 2025. Kozlik's work on McKibben-type artificial muscles dates back to 2014, and an early robotic arm prototype was published in 2019 under the Automaton Robotics name.
Core technology. Clone's proprietary Myofiber is a monolithic musculotendon unit attached to anatomically accurate points on the bones; the company says this construction prevents tendon failures. Its stated target performance for a single 3 g fiber is a response time under 50 ms, more than 30% unloaded contraction and at least 1 kg of contraction force. The muscles are hydraulically actuated with water, and the robots run on water and electricity.
Products. The Clone Hand was the company's first product line; after eight years of R&D the hand uses back-drivable, antagonistic muscles and tendons, an opposable thumb, a rounded palm and soft muscle, fat and skin layers. Clone lists motions such as finger abduction/adduction, lumbrical flexing and full wrist flexion, deviation and pronation/supination, and shows the index finger pulling a power-drill trigger; successive versions include the Synthetic Hand v18 (2023), a ligament-based V19 and a teleoperated V2 hand. Clone Alpha is a bipedal android companion for individuals and businesses, sold as an 'Alpha edition' with pre-orders on the company website; it is described as a soft-bodied, featherweight android that converses in natural language through large language models and uses edge GPU compute. A full-body prototype, Protoclone, was shown in video in February 2025, and Neoclone is listed as in development. Demonstrations to date have shown suspended-frame movement rather than independent walking.
Funding. Investors reported for the company include Initialized Capital, Pioneer Fund, Lux Capital and angel investor Trevor Blackwell, and the company has also raised money through equity crowdfunding on Republic.
Primary type & automation activities this supplier delivers:
Clone Alpha
Bipedal musculoskeletal android companion actuated by water-driven Myofiber muscles; pre-orders open.
Clone Hand
Musculoskeletal robotic hand with antagonistic Myofiber muscles, tendons and an opposable thumb.
Myofiber
Monolithic hydraulic musculotendon artificial muscle fiber used across Clone robots.
More related news
- 1
- 2
- 3
- 4
-
5
IROS 2026 Best Paper Finalists: South Korea Leads RobotToday · Oct 07, 2026
-
6
IEEE ARSO 2027 Mountain View: Mar 13–15 | Robotics & Society RobotToday · Oct 06, 2026
-
7
ISMR 2027: Medical Robotics Symposium, Nashville RobotToday · Oct 06, 2026
-
8
ROSCon Global 2027, Kraków, Oct 12–14 RobotToday · Oct 06, 2026
-
9
AGRITECHNICA 2027 Hanover: Nov 14-20 | Ag Machinery RobotToday · Oct 06, 2026
-
10
WRC 2027: World Robot Conference, Beijing, opens Aug 18 RobotToday · Oct 06, 2026
-
11
IEEE CASE 2027 Linz: Aug 23–27 | Automation Science RobotToday · Oct 06, 2026
-
12
ICARA 2027: Automation & Robotics Conference, Paris RobotToday · Oct 05, 2026
- 13
- 14
- 15
- 16
-
17
Laser Weeding Robotics 2025 Carbon Robotics Global Lead Vs Hg Tech S China Challenge RobotToday · Nov 23, 2025
- 18
-
19
Humanoid Robot Wars: Factory First or Home RobotToday · Oct 31, 2025
- 20
Contact Clone Robotics
WEBSITE
https://clonerobotics.comHEADQUARTERS
Poland
Company Facts
Founded
2021
Primary Role
Manufacturer
Company Size
-
Primary Region
Europe
Annual Sales
-
Funding Stage
Early-Stage VC
Funding Total
-
